A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ ...
The "First Opinion Podcast" is back. This week, new host @thekibosch moderates a...
Tobacco giant RJ Reynolds is threatening to sue vape shops if they do not stop s...
Biden’s presumed NIH pick, cancer official Monica Bertagnolli, will face a slew ...
Some countries with a tradition of training nurses "for export," like the Philip...
23AndMe CEO Anne Wojcicki was among the health data experts who convened to disc...
Despite the significant advances that have been made in the immuno-oncology fiel...
In this video interview, Dirk Borghs, CEO Datwyler Healthcare Solutions, talks t...
Rhenium (186Re) obisbemeda has been formulated for safe delivery of highly targe...
BD is a rare multisystem inflammatory vasculitis, which currently has no treatment.
The firms will sign a long-term contract that will help Marker fully focus on th...
The newly granted status helps Erasca facilitate the development and review of E...
The use of these current vaccines is important from a public health perspective ...
Bristol Myers Squibb will continue the development, manufacturing, and commercia...
The FDA granted Memo Therapeutics a fast track designation for its BK polyomavir...
Expansion of ODAIA’s platform will allow pharma companies to rapidly deliver lif...
